• 28: Novo Nordisk's Bold Leap into Rare Diseases

  • 2025/03/12
  • 再生時間： 9 分
  • ポッドキャスト

28: Novo Nordisk's Bold Leap into Rare Diseases

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Novo Nordisk is strategically expanding into rare diseases, shifting from its traditional focus on common chronic conditions, by significantly increasing R&D investment and executing key acquisitions to build a strong portfolio in blood, endocrine, and hemato-renal disorders. The company aims to achieve long-term leadership in this space through internal innovation, strategic partnerships, and further mergers and acquisitions.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示

あらすじ・解説

Novo Nordisk is strategically expanding into rare diseases, shifting from its traditional focus on common chronic conditions, by significantly increasing R&D investment and executing key acquisitions to build a strong portfolio in blood, endocrine, and hemato-renal disorders. The company aims to achieve long-term leadership in this space through internal innovation, strategic partnerships, and further mergers and acquisitions.

Hosted on Acast. See acast.com/privacy for more information.
続きを読む 一部表示

28: Novo Nordisk's Bold Leap into Rare Diseasesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。